Skip to content

Study on the Correlation between Vascular Complications of Senile Diabetes Mellitus and CXCL14

Study on the Correlation between Vascular Complications of Senile Diabetes and CXCL14 and Optimization of Stratified Management Process

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122574
Enrollment
Unknown
Registered
2026-04-15
Start date
2025-11-03
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Combine at least one diabetic microvascular complication:None

Sponsors

General Hospital of the Western Theater Command of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Common inclusion criteria (both groups must meet): (1)Age > 60 years; (2)Underlying disease: meeting the WHO 2023 diagnostic criteria for diabetes; (3) Disease duration = 5 years (to ensure sufficient duration for the development of complications); (4) HbA1c fluctuation within 6.5-9.0 in the past 3 months (to control the interference of extremely high blood glucose); (5)Voluntary participation and signing of the informed consent form. 2. Experimental group (microvascular complications group): Complicated with at least one diabetic microvascular complication: (1) Diabetic nephropathy (proteinuria (UACR = 30 mg/g) for 2 consecutive times or eGFR < 60 ml/min/1.73m², excluding other nephropathies); (2) Diabetic retinopathy (ETDRS stage = non-proliferative stage, with clear diagnosis by fundus angiography/OCT). 3. Specific criteria for the control group (no complications group): All must be met: (1) Normal urinary albumin excretion (UACR < 30 mg/g); (2) Fundus examination excludes signs of diabetic retinopathy, including macular edema, macular hemorrhage, microaneurysms, etc.; (3)Age matched with the experimental group.

Exclusion criteria

Exclusion criteria: 1.Acute or chronic infection, with peripheral blood high-sensitivity C-reactive protein > 10mg/L; 2. History of malignant tumors; 3. Autoimmune diseases; 4. History of major surgery/blood transfusion within 3 months; 5.Use of immunosuppressants/biologics; 6.Type 1 diabetes.

Design outcomes

Primary

MeasureTime frame
CXC motifligand 14, CXCL14;Fasting blood glucose;glycated hemoglobin;C-peptide;

Secondary

MeasureTime frame
blood lipids;Renal function;Liver function;Urinalysis;Urinary microalbumin to creatinine ratio;Fundus condition;

Countries

China

Contacts

Public ContactKe Yu

General Hospital of the Western Theater Command of the Chinese People's Liberation Army

yuke909@126.com+86 135 6899 9061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026